Publications
Assessment of the FDA risk evaluation and mitigation strategy for transmucosal immediate-release fentanyl products
Rollman JEHeyward JOlson LLurie PSharfstein JAlexander GC. Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl Products. JAMA. 2019;321(7):676–685. doi:10.1001/jama.2019.0235
How is the COVID-19 pandemic shaping transportation access to health care?
Katherine L. Chen, Madeline Brozen, Jeffrey E. Rollman, Tayler Ward, Keith C. Norris, Kimberly D. Gregory, Frederick J. Zimmerman, How is the COVID-19 pandemic shaping transportation access to health care?, Transportation Research Interdisciplinary Perspectives, Volume 10, 2021, 100338, ISSN 2590-1982, https://doi.org/10.1016/j.trip.2021.100338.